Prevent Blindness declares May 15-21, 2023, as the 4th annual “Inherited Retinal Disease (IRD) Genetic Testing Week.”

“By providing IRD patients with the resources they need to learn more about their diagnosis, as well as how gene therapy may benefit them, we are working to continue to preserve vision,” said Jeff Todd, president and CEO of Prevent Blindness.

CHICAGO (PRWEB)
May 09, 2023

Prevent Blindness, the nation’s leading nonprofit eye health and safety organization, has declared May 15-21, 2023, as the fourth annual “Inherited Retinal Disease (IRD) Genetic Testing Week.” An IRD is a genetic disorder that can cause severe vision loss or even blindness. IRDs include Retinitis Pigmentosa (RP), Choroideremia, Stargardt Disease, Cone-rod Dystrophy and Leber Congenital Amaurosis. Early detection and treatment can help to prevent significant vision loss. Genetic testing is now available to identify many gene variants that cause IRDs.

To help raise awareness and educate the public on IRDs and the importance of genetic testing, Prevent Blindness offers a dedicated web resource, PreventBlindness.org/inherited-retinal-diseases. Educational videos, shareable social media graphics, and fact sheets in English and Spanish are available.

On Tuesday, May 16, at 3 p.m. ET, the National Center for Children’s Vision and Eye Health at Prevent Blindness will be hosting the free webinar, “Inherited Retinal Diseases and Children’s Vision and Eye Health: What You Need to Know.” This webinar is designed for a wide audience, including parents and families, school nurses, Head Start and other early childhood program staff, early intervention and special education professionals, teachers of students with visual Impairments, state vision rehabilitation staff, parent and patient support organizations, primary care providers, and eye care providers.

Panelists to include:

• Donna Hunt Hodge, MBA, Director of Marketing, Retina Gene Therapies, Janssen Pharmaceutical Companies of Johnson & Johnson
• Arlene Drack, MD, Ronald Keech Professor of Pediatric Genetic Eye Disease Research, Director, Electrophysiology, Institute for Vision Research, Department of Ophthalmology and Visual Sciences, University of Iowa
• Sherry Day, OD, FAAO, Clinical Assistant Professor, Ophthalmology and Visual Sciences Section Leader, Vision Care, Contact Lens and Low Vision Rehabilitation, University of Michigan
• Kari Branham, MS, CGC, Clinical Assistant Professor, Ophthalmology and Visual Sciences and Genetic Counselor, Inherited Retinal Dystrophy Clinic, University of Michigan
• Mariagrazia Buttitta, MA, NCC, Patient with Cone Dystrophy, and national Certified Counselor, author, motivational speaker, career coach, wellness and health enthusiast, and mental health and disability advocate
• Allison Galloway, FNP-C, MS, SA, Parent of two children with LCA13, a childhood degenerative retinal disease and certified Family Nurse Practitioner, master’s prepared in Food and Science, and a certified Surgery Assistant

Additionally, as part of the Prevent Blindness Focus on Eye Health Expert Series, Alina V. Dumitrescu, M.D., Clinical Associate Professor of Ophthalmology and Visual Sciences, Pediatric Ophthalmology and Strabismus, Inherited Eye Disease at the University of Iowa Hospitals and Clinics, is featured in the episode, “Inherited Retinal Disorders and Genetic Testing.”

Also, two graduates of the ASPECT (Advocacy, Support, Perspective, Empowerment, Communication and Training) Patient Engagement Program at Prevent Blindness, share their perspective and experience of living with an IRD. Brenda Niccum, who has RP, and Mariagrazia Buttitta, who has cone dystrophy, discuss their conditions as well as ways they manage their vision impairments. Founded in 2020, ASPECT aims to equip participants with knowledge, skills, and confidence to become advocates for vision and eye health at the individual, peer-to-peer, community, state and/or national levels.

The 2023 IRD Genetic Testing Week at Prevent Blindness is supported by Janssen Pharmaceutical Companies of Johnson & Johnson and Spark® Therapeutics, a fully integrated company and member of the Roche group. Janssen offers the EyesOnGenes resource, a comprehensive website for patients and health care providers with information on IRDs, genetic testing benefits, community resources and more. Spark offers educational resources on IRDs and genetic testing through the Eye Want 2 Know® website.

Prevent Blindness strongly encourages patients to talk to their eye doctors about genetic testing. Having the genetic diagnosis will help to identify potential treatment options for patients, inform them about the potential risk of disease to other family members and identify the potential risk to other organs in the patient’s body that may be affected.

For those interested in participating, the Prevent Blindness Living Well With Low Vision resource has a dedicated listing of clinical trials for diseases of the retina. The newly redesigned site also provides free resources for low vision patients, including the “Self-help Guide to Non-Visual Skills,” and care partners, such as “The ABCs of Caring for the Visually Impaired.”

“The many recent advancements in treatment for eye diseases have been truly remarkable,” said Jeff Todd, president and CEO of Prevent Blindness. “By providing IRD patients with the resources they need to learn more about their diagnosis, as well as how gene therapy may benefit them, we are working to continue to preserve vision.”

For more information on IRDs and genetic testing for vision issues, visit PreventBlindness.org/inherited-retinal-diseases. To register for the Inherited Retinal Diseases and Children’s Vision and Eye Health: What You Need to Know webinar, visit PreventBlindness.org/ird-webinar. For a listing of vision care financial assistance programs in English or Spanish, visit PreventBlindness.org/vision-care-financial-assistance-information.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at PreventBlindness.org, and follow us on Facebook, Twitter, Instagram, LinkedIn and YouTube.

###

Share article on social media or email:

“I am very thankful to Women We Admire for their recognition of my hard work, as well as for their work inspiring female leaders throughout the country,” said Catherine Downey, founder and CEO of CATMEDIA.

TUCKER, Ga. (PRWEB)
May 09, 2023

CATMEDIA founder and CEO Catherine Downey was recently recognized among The Top 50 Women Leaders of Georgia for 2023 by Women We Admire in their most recent listing.

The Top 50 list was compiled based on a methodical review of women executives and leaders across the area. It includes women from Kohl’s, Deloitte, and University of Georgia.

“It really is a true honor to be on a list with so many strong and successful women,” says Downey.

Downey’s exceptional experience and continued dedication has been recognized through this and numerous other recognitions, including her feature among Atlanta magazine’s 500 most powerful leaders each of the past five years.

Women We Admire Recognizes, Informs, and Inspires

Women We Admire is a membership organization comprised of over 1,200 of the most accomplished women leaders in business, law, consulting, education, non-profit as well as other industries.

They are a provider of news and information about today’s women leaders in business, entertainment, sports, motherhood, medicine, law, and many other industries that covers a variety of topics with the goal of recognizing the achievements of outstanding women. They also aim to inspire others to aim high and to continue towards their full potential.

Women We Admire, and its affiliates, has a reach of over 32,000 individuals and businesses.

About CATMEDIA

CATMEDIA is an award-winning agency that specializes in advertising, creative services, media production, program management, and leadership training. As a national leader that works with highly regulated clients, breaks down complex issues, and effectively communicates to a wide array of audiences, this Women-Owned Small Business (WOSB) provides world-class customer service and innovative solutions to commercial and government clients, alike, including the Centers for Disease Control and Prevention (CDC), Federal Aviation Administration (FAA), and Department of Veterans Affairs (VA).

Share article on social media or email:

John McDonnell, President and CEO of Evive

John is a strong, hands-on leader with a clear understanding of business economics and key value drivers that uniquely position him to take Evive into its next growth stage.

CHICAGO (PRWEB)
May 09, 2023

Evive, the leader in digital engagement and communications technology, today announced that after five years with the company, John McDonnell has been promoted to president and CEO. McDonnell succeeds Prashant Srivastava, who served as president and CEO since 2017 after Peter Saravis, who co-founded Evive with Srivastava in 2007, and was CEO from 2007-2017, stepped down.

Under the new leadership structure, Srivastava will transfer to executive chairman of Evive’s Board of Directors and support the ongoing successful execution of Evive’s long-term strategic plan. Saravis assumed the role of executive chairman in 2017, and will continue to serve on Evive’s Board, maintaining an active role in identifying and planning strategies that drive ongoing growth and product innovation for the company.

“I am tremendously grateful and honored to be the next president and CEO of Evive and follow in Prashant’s footsteps,” said McDonnell. “Prashant has done an outstanding job in this role over the last 16 years and has assembled a great team. Under his leadership, we have reached record growth, have continued to add outstanding talent, and have achieved significant product success within many areas of our business.”

McDonnell joined Evive in 2018, first serving as chief financial officer and adding chief operations officer to his title in December 2019. With over 25 years of business and financial management experience, McDonnell has a successful track record helping companies grow, supporting strategy development and enabling execution.

Previously, McDonnell was CFO at Infogix, Inc., a leading provider of data solutions, where he oversaw finance, revenue management, accounting and risk management. Earlier in his career, John held finance and accounting roles at SAVO and Interface Software.

“John is a strong, hands-on leader with a clear understanding of business economics and key value drivers that uniquely position him to take Evive into its next growth stage,” said Srivastava. “Peter and I started Evive to help employees get more from their benefits and help employers better understand the value of their investment across their entire benefit and resource ecosystem. As we continue to build the leading digital communications and engagement platform serving hundreds of employers and millions of employees each year, we’re confident John has the depth and breadth of experience to continue that mission and capitalize on the many opportunities ahead.”

To learn more about Evive or schedule a demonstration, please visit http://www.goevive.com. To keep up with Evive, read the Evive blog or stay connected by following Evive on LinkedIn.

About Evive

Evive is a digital communications and engagement platform that helps health plans, benefit administrators and employers optimize the benefits, resources and programs they offer their employees. Using data-driven personalization, closed-loop engagement reporting and the power of predictive analytics and behavioral science, Evive increases benefits awareness, engagement and utilization to deliver the right message about the right benefit at the right time. To learn more about Evive, visit http://www.goevive.com or LinkedIn.

Share article on social media or email:

ClinEco Welcomes a New Advisor

ClinEco plans on leaning heavily on Rob’s diverse expertise in the management of online marketplaces and startup growth as we work to deliver the best possible experiences of all clinical research stakeholders.

NEEDHAM, Mass. (PRWEB)
May 09, 2023

ClinEco, the world’s first online community for clinical trial organizations to explore, engage and exchange capabilities with an ecosystem of partners, announced today that it has named Rob Ristagno, President of International Operations at Vistage Worldwide, to its advisory board. In his role, Ristagno will counsel ClinEco leadership as they plan their next chapter of growth for the clinical trial partnership platform.

“We are thrilled to have Rob as one of our advisors. Rob’s experience is different from the rest of our team, as his background is not in clinical research but rather in helping companies grow. This makes him a great complement to the rest of our advisory board and a valuable member of our team,” said Micah Lieberman, Co-Founder and VP of Community and Business Development at ClinEco. “We plan on leaning heavily on Rob’s diverse expertise in the management of online marketplaces and startup growth as we work to deliver the best possible experiences for all our clinical research stakeholders.”

In Ristagno’s current role with Vistage Worldwide, he is focused on building the company’s footprint globally, particularly in Europe, the Middle East and Africa (EMEA) as well as the Latin American and Asia Pacific regions. His previous experience includes building and growing a tech-enabled consultancy, Sterling Woods, where he and his team created over a half billion dollars of enterprise value for small and medium sized businesses. Ristagno’s background also includes time at McKinsey & Company, America’s Test Kitchen and Homesite Insurance in growth-focused executive roles as well as positions at global brands Visa, Pepsi and Comcast. He is a published author, keynote speaker and serves on the board of DRG Holdings. Rob holds an MBA from Harvard Business School and a BA in economics from Dartmouth College and has taught at both Harvard and Boston College.

About ClinEco

ClinEco unites sponsors, CROs, service providers and sites on the world’s first B2B clinical trial marketplace, empowering all to expand clinical partnerships. Through creating a platform where all clinical research stakeholders can explore, engage, and exchange capabilities with an ecosystem of partners, ClinEco accelerates the process of vendor selection, leading to faster, more efficient clinical trials. ClinEco is a Cambridge Healthtech Institute Company. The team responsible for ClinEco is also the team behind the Summit for Clinical Ops Executives (SCOPE).

About CHI

Cambridge Healthtech Institute (CHI) believes bringing together a unique and diverse constellation of innovators, scientists, and life science professionals can hold the key to developing tomorrow’s cures and diagnostics. We are a life science network for leading researchers and business experts from top pharmaceutical, biotech, and academic organizations.

Share article on social media or email:

Szekely is 101 years young and is the embodiment of the lifestyle of proactive wellness that she has long promoted. ‘I didn’t expect to live to 100 – it just happened.’

MIAMI (PRWEB)
May 09, 2023

In celebration of Deborah Szekely’s 101st birthday this month (May 3rd), the Global Wellness Summit is releasing a very special episode (#71) of its Global Wellness Conversations podcast entitled “A Mentor, Two Mavens & the Birth of a Movement,” which is streaming live on all podcast platforms starting Wednesday, May 10.

The podcast features Szekely, a wellness visionary decades before anyone even began using the term, who is co-founder of Rancho La Puerta and founder of Golden Door, in conversation with Susie Ellis, her mentee, and a leading voice in wellness as chair and CEO of the Global Wellness Summit and the nonprofit Global Wellness Institute. The two industry veterans discuss their decades-long experiences in the wellness trenches, while Szekely shares insights and philosophies on longevity – one of today’s hottest topics.

Szekely “walks the wellness walk” and, at 101 years young, is the embodiment of the lifestyle of proactive wellness that she has long promoted. “I didn’t expect to live to 100 – it just happened,” says Szekely. “There’s not going to be a breakthrough that brings you eternal life. It’s all very simple. It’s about doing what you know is right.”

“I think Deborah is the best advertisement for the philosophy of the Golden Door and Rancho La Puerta – heathy eating, movement, taking care of your mental health, stress reduction, and the importance of healthy relationships,” said Ellis.

The podcast not only sheds light on the wellness practices that have helped shaped Szekely’s long and healthy life, but also her successful leadership that enabled her to build a business that continues to thrive, grow and evolve 80 years later.

Ellis began working with Szekely in the 1970s, when she was hired to work at the Golden Door, her first job in the spa and wellness industry. After working at the Golden Door for decades, she went on to obtain an MBA at UCLA and to help launch a number of high-profile spas. This experience led her to the realization that the wellness industry would never be taken seriously without a more evidence-based approach and some serious economic research figures to measure its many sectors. Today, she heads up the leading global research and advocacy organizations for the $4.4T global wellness economy.

Also discussed on the podcast:

• Some of the early wellness, fitness and spa practices that were born at Ranch La Puerta
• Notable visitors to Rancho La Puerta and why The Golden Door was created as a “sister” destination spa
• How these two female leaders achieved success in a male-dominated business world
• The “why” behind Rancho La Puerta’s entry into wellness real estate
• The ways Szekely’s workplace wellness strategies have impacted Ellis’ own leadership

While being interviewed by Kim Marshall, host of the Summit’s Global Wellness Conversations Podcast, it became clear that these two powerful women each had a vision and stuck to it.

The episode, which is sponsored by KOHLER, a legendary brand celebrating 150 years of delivering wellness through water, will be available to the public May 10th, but an earlier video cut available is here. Images to accompany the story are here.

About the Global Wellness Summit: The Global Wellness Summit is an organization that brings together leaders and visionaries to positively shape the future of the $4.4 trillion global wellness economy. In addition to an annual conference, held at a different location around the globe, GWS also hosts regular virtual gatherings, including Wellness Master Classes and collaborative Wellness Sector Spotlights. Each year, it holds an in-person Wellness Real Estate & Communities Symposium. The organization’s annual Global Wellness Trends Report offers expert-based predictions on the future of wellness that are oft-quoted in the media. The 17th annual GWS will be held in Qatar from November 6-9, 2023.

Share article on social media or email:

We’ve heard from many of our Medical Device customers that no single solution helps them ensure compliance and consistency throughout their device lifecycle. We set out to fix that with the new Risk Solutions by providing the only ISO 14971-aligned system along with AI-powered insights.

INDIANAPOLIS (PRWEB)
May 09, 2023

Greenlight Guru, the leading provider of cloud-based software for MedTech companies, today announced the launch of Risk Solutions, a first-of-its-kind, complete risk management software that pairs AI-generated insights with intuitive risk management workflows.

According to the 2023 MedTech Industry Benchmark Report, one of the top challenges cited for managing design and development activities was implementing risk control measures. Greenlight Guru’s Risk Solutions provides a smarter way for MedTech teams to manage risk for their device(s) and business. The complete solution consists of two components:

• 
  Risk Intelligence helps users identify and assess the most relevant risks for their devices using AI and advanced statistical models powered by real-world data to provide insights and recommendations for their device(s).
• Risk Management provides visually intuitive, collaborative workflows for creating risk matrices and documenting risk. It is the only solution in the industry that aligns with ISO 14971:2019 while providing complete traceability throughout the entire device lifecycle.

“Risk assessments are a fundamental part of bringing safe medical devices to market,” said Tyler Foxworthy, Chief Data Scientist of Greenlight Guru. “Historically, risk assessment has been a complex, heuristically driven process for teams. Our goal with Risk Intelligence is to make that process better and more comprehensive for our customers by making relevant risk data and long-established statistical risk assessment models more accessible and less intimidating.”

Greenlight Guru’s novel search engine leverages machine learning and natural language processing to aggregate industry data from sources like the FDA MAUDE database. With applied statistical models and AI, Risk Intelligence enables searches by product codes, indications for use, and intended use to identify and recommend potential risks.

Greenlight Guru’s customers are eagerly anticipating the new Risk Intelligence solution. According to Brad Cunningham, Director of Quality Assurance from Pirouette Medical, “this will save lots of time normally spent brainstorming, researching, and documenting hazards, patient harms, and trying to estimate probabilities and severities. I enjoy that we can combine our existing expertise with AI-driven insights derived from regulatory databases to best evaluate risk for our device.”

Additionally, Greenlight Guru’s enhanced Risk Management software includes intuitive and time-saving features, like in-line editing for creating and documenting risk activities, auto-calculated estimated risk probabilities, and continuously updated IMDRF codes. The result is a powerful solution for MedTech companies to improve their risk management process, drive more efficiency and confidence, and ultimately get safer devices to market.

“Managing risk is a critical and continuous activity for medical device companies,” said David DeRam, CEO of Greenlight Guru. “We’ve heard from many of our Medical Device customers over the years that no single solution helps them ensure compliance and consistency throughout their device lifecycle. We set out to fix that with the new Risk Solutions by providing the only ISO 14971-aligned system along with AI-powered insights. This is the biggest advancement in the industry since we launched our original eQMS over ten years ago. We are excited to share this revolutionary technology to help our customers build innovative medical devices that improve the quality of life.”

To learn more about the new Risk Solutions software or request a demo, visit https://www.greenlight.guru/risk-solutions.

About Greenlight Guru

Greenlight Guru provides the leading cloud-based solutions for MedTech companies to bring life-changing products to people faster, and with less risk. Greenlight Guru provides purpose-built quality management, product development, and clinical data management solutions that together help teams accelerate timelines, streamline compliance, and deliver high-quality products. With Greenlight Guru, companies across the globe are improving efficiency, speed, and quality in every aspect of their organization to get products to market faster and keep them on the market longer. For more information, visit http://www.greenlight.guru.

Media Contact

PR at Greenlight Guru

pr@greenlight.guru

Share article on social media or email:

The RCO is a new service partner that has emerged in response to the shifting landscape of drug and device development outsourcing.

TORONTO (PRWEB)
May 09, 2023

In this webinar, the featured speakers will showcase the success of ProPharma’s new Research Consulting Organization (RCO) model, which offers a refreshing approach to drug and device development outsourcing, addressing the challenges faced by smaller and mid-sized innovators with traditional Contract Research Organizations (CROs) that prioritize larger programs. The new RCO delivers a “3-D printed” solution for those sponsor programs that just don’t fit the mold.

The RCO is a new service partner that has emerged in response to the shifting landscape of drug and device development outsourcing. Historically, smaller and mid-sized innovators have found themselves relegated to the end of the queue, piecing together pivotal programs with the CRO’s “C” team. The RCO model offers a new degree of personalization and agility, which is not typically available with rigid CRO models, to meet this need. With smaller rare disease programs representing 40 percent of the industry’s pipeline, the “bigger-the-better” CRO trend has become incongruent with market needs. Traditional CROs are trapped in scale-based economic models, and the “need volume to make the numbers work” mindset, which often results in extraneous services being pushed to help drive appeal and boost margin.

Register for this webinar to discover a personalized approach to drug and device development outsourcing for smaller and mid-sized innovators.

Join Bryan Katz, Chief Strategy Officer/Head of Corporate Development, ProPharma; Sara Sorrentino, Executive Vice President, Business Development, ProPharma; and David Dobrowski, VP of Clinical Development and Regulatory Affairs, ABK Biomedical, for the live webinar on Monday, May 15, 2023, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit Drug and Device Development Outsourcing with the Research Consulting Organization (RCO) Model.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

GURNEE, Ill. (PRWEB)
May 09, 2023

BrightStar Care, the leading national home care and medical staffing agency with more than 380 corporate-owned and franchised locations known for providing a higher standard of home care, was awarded The Joint Commission 2023 Enterprise Champion for Quality Award for the eleventh consecutive year, reinforcing the brand’s commitment to the highest standards of quality and safety in home care.

BrightStar Care is the only home care organization to achieve this title for more than a decade, with more than 95 percent of its corporate and independently owned and operated offices accredited by The Joint Commission, the nation’s oldest and largest standards-setting and accrediting body in healthcare. Additionally, BrightStar Care is one of only two franchisors to receive this title since the award’s inception in 2013.

Receiving the Gold Seal of Approval® from The Joint Commission means that healthcare organizations have completed a comprehensive on-site review and precisely follow the standards and requirements established by The Joint Commission. To achieve accreditation, organizations must incorporate and consistently maintain Joint Commission standards and requirements into their policies, procedures, processes, and training materials. Joint Commission accreditation helps organizations improve safety procedures, which has become even more crucial for patient care since the onset of the COVID-19 pandemic.

“Our top priority across the entire BrightStar Care network is to deliver a higher standard of care to our clients, so they have the ability to receive treatment and care safely and independently in the comfort of their homes,” said Shelly Sun, Founder and CEO of BrightStar Care. “We are grateful that The Joint Commission continues to recognize our efforts and has once again awarded us with its prestigious Enterprise Champion for Quality Award. As we diversify our offerings across a wide payer mix and increase our customer count to reach the total addressable market eligible for home care, we remain committed to providing the full continuum of care. With this award, we will continue to collaborate with our franchisees to ensure that our clients receive industry-leading, high-quality nurse-led care.”

“We are pleased to recognize BrightStar Care with the Enterprise Champion for Quality Award for the eleventh consecutive year,” said Gary Bachrach, Executive Director, Home Care Accreditation Program, The Joint Commission. “We applaud the BrightStar Care organization for its commitments and efforts working closely with its franchisees to continue to improve quality and safety for the many individuals and families it serves nationwide.”

Joint Commission accreditation is a known quality indicator within the industry. It is the same organization that accredits and certifies more than 22,000 healthcare organizations and programs in the United States. Joint Commission accreditation has allowed BrightStar Care to help its clients continue to live safely in their own homes and improve the quality of their lives, as well as to help prevent hospital re-admissions and decrease ER visits, falls, infections, and unnecessary healthcare costs for clients.

Backed by third-party validators BrightStar Care’s proven clinical outcomes are driven by nurse-led care comprised of companion care, personal care, pediatric care, memory care, medication assistance, skilled nursing, and more to improve each client’s health and quality of life. For more information on BrightStar Care, please visit http://www.brightstarcare.com, and for more information about franchising opportunities with BrightStar Care visit https://www.brightstarfranchising.com/. For more information about The Joint Commission, please visit http://www.jointcommission.org.

About BrightStar Care:

Founded in 2002, BrightStar Care is a national home care agency with more than 380 corporate-owned and franchised locations nationwide that provide medical and non-medical home health care services to clients and supplemental care staff to businesses. BrightStar Care corporate and franchise agencies across the country employ more than 15,000 caregivers and 5,700 registered nurses who oversee the care and safety of each individual client. BrightStar Care offers custom medical staffing solutions to corporate entities and holds national accounts with government agencies across distinct patient populations providing healthcare staff anywhere care is needed. Female-founded and led by CEO Shelly Sun; BrightStar Care is committed to providing a higher standard of care through its clinical nurse-led care model. As a member of Moving Health Home, BrightStar Care also actively advocates to change federal and state policies that prevent the home from being an accredited clinical care site. Network-wide BrightStar Care agencies are Joint Commission accredited – the gold standard within the health care industry. BrightStar Care has also consecutively received The Joint Commission Enterprise Champion for Quality award for more than a decade.

Share article on social media or email: